MAPT and Alzheimer disease: Thus, to clarify the mechanistic link between irisin and AD, we studied a biologically defined cohort of 146 patients according to the amyloid/tau/neurodegeneration (ATN) scheme of the National Institute on Aging–Alzheimer's Association (NIA‐AA) [15].